Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001808805-25-000032·Nautilus Biotechnology, Inc.
Schedule 13D ownership disclosure
Nautilus Biotechnology, Inc.
Common stock, par value $0.0001 per share · CUSIP: 63909J108
Event date: 2025-03-03
- Filing-level shares
- 20,297,732.00
- Percent of class
- 15.7%
- Sujal PatelReported CIK 0001378830
Shares: 20,297,732.00 · Class: 15.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001808805-25-000032
- Form type
- SCHEDULE 13D/A
- Filer
- Nautilus Biotechnology, Inc.
- CIK
- CIK 1808805
- Filed
- Mar 05, 2025
- Reporting period
- Mar 03, 2025
- Description
- Schedule 13D beneficial ownership